We are live on
!
Find out more
1CM
1492 Capital Management Portfolio holdings
AUM
$263M
1-Year Est. Return
61.9%
This Fund
S&P 500
This Quarter
Est. Return
-1.56%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$139M
AUM Growth
-$13.2M
(-8.7%)
Cap. Flow
-$3.41M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
30.84%
Holding
132
New
20
Increased
32
Reduced
34
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$2.51M |
| 2 |
SKX
Skechers
SKX
|
+$2.01M |
| 3 |
Lyft
LYFT
|
+$1.93M |
| 4 |
MP Materials
MP
|
+$1.84M |
| 5 |
Accel Entertainment
ACEL
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LTHM
Livent Corporation
LTHM
|
+$4.82M |
| 2 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$3.52M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$3.03M |
| 4 |
Korn Ferry
KFY
|
+$2.44M |
| 5 |
ProPetro Holding
PUMP
|
+$2.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.32% |
| 2 | Healthcare | 19.56% |
| 3 | Consumer Discretionary | 12.44% |
| 4 | Industrials | 9.37% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Shift4
FOUR
$3.26B
| $909K | 0.65% |
20,375
-4
| -0% | -$168 |
|
52
Third Coast Bancshares
TCBX
$738M
| $894K | 0.64% |
52,261
-14
| -0% | -$274 |
|
53
GXO Logistics
GXO
$5.55B
| $859K | 0.62% |
+24,491
| New | +$1.08M |
|
54
Pacira BioSciences
PCRX
$997M
| $859K | 0.62% |
16,153
-3
| -0% | -$167 |
|
55
PENN Entertainment
PENN
$2.71B
| $855K | 0.62% |
31,088
-934
| -3% | -$30.2K |
|
|
ARGO
56
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $845K | 0.61% |
43,867
+3,310
| +8% | +$86.8K |
|
57
Chegg
CHGG
$102M
| $806K | 0.58% |
+38,231
| New | +$792K |
|
58
Arcus Biosciences
RCUS
$3.64B
| $804K | 0.58% |
30,744
-6
| -0% | -$159 |
|
59
DraftKings
DKNG
$11.9B
| $799K | 0.58% |
52,776
-14
| -0% | -$223 |
|
60
Dynatrace
DT
$14.2B
| $799K | 0.58% |
22,948
-11
| -0% | -$425 |
|
61
CRISPR Therapeutics
CRSP
$5.17B
| $785K | 0.57% |
12,005
-3
| -0% | -$217 |
|
|
EBIX
62
DELISTED
Ebix Inc
EBIX
| $768K | 0.55% |
40,498
+15,249
| +60% | +$336K |
|
63
Universal Display
OLED
$4.19B
| $747K | 0.54% |
7,919
-3
| -0% | -$332 |
|
64
Tandem Diabetes Care
TNDM
$1.56B
| $717K | 0.52% |
14,993
-60
| -0.4% | -$3.29K |
|
|
NEXN
65
Nexxen International
NEXN
$607M
| $689K | 0.5% |
99,427
-110,068
| -53% | -$969K |
|
|
AXDX
66
DELISTED
Accelerate Diagnostics
AXDX
| $684K | 0.49% |
+44,975
| New | +$744K |
|
67
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
| $683K | 0.49% |
15,394
| – | – |
|
68
HighPeak Energy
HPK
$910M
| $674K | 0.49% |
31,107
-4,400
| -12% | -$104K |
|
|
VRNA
69
DELISTED
Verona Pharma
VRNA
| $673K | 0.48% |
+65,862
| New | +$555K |
|
70
Five Below
FIVE
$13.5B
| $651K | 0.47% |
+4,728
| New | +$621K |
|
|
CHUY
71
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $649K | 0.47% |
+27,990
| New | +$625K |
|
72
Intellia Therapeutics
NTLA
$1.67B
| $625K | 0.45% |
11,173
+217
| +2% | +$13.5K |
|
73
ANI Pharmaceuticals
ANIP
$1.78B
| $584K | 0.42% |
18,178
| – | – |
|
|
CALY
74
Callaway Golf Company
CALY
$3.14B
| $577K | 0.42% |
+29,951
| New | +$662K |
|
75
Crocs
CROX
$6.55B
| $571K | 0.41% |
+8,311
| New | +$577K |
|
Similar funds
KA
DEA
EAN
SC
L
LB
ACM
TSW
1492 Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, 1492 Capital Management held 132 positions worth $139M, down 8.7% from $152M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
1492 Capital Management's Q3 2022 filing shows 20 new, 32 increased, 34 reduced and 26 closed positions. Its largest new stake was Qualtrics International Inc. Class A Common Stock: 201,995 shares worth $2.06M. The largest sale was Livent Corporation, an estimated $4.82M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- 1492 Capital Management's largest Q3 2022 buy was Qualtrics International Inc. Class A Common Stock: 201,995 shares worth $2.06M.
- 1492 Capital Management added most to Skechers in Q3 2022, an estimated $2.01M increase.
- 1492 Capital Management's biggest Q3 2022 reduction was Livent Corporation, cutting an estimated $4.82M.
- 1492 Capital Management fully exited Syneos Health, Inc. Class A Common Stock in Q3 2022, selling an estimated $3.52M.
- 1492 Capital Management's ten largest holdings make up 31% of its $139M portfolio in Q3 2022.
- 1492 Capital Management opened 20 new positions and closed 26 in Q3 2022.
- 1492 Capital Management's portfolio value fell 8.7% quarter-over-quarter to $139M.
Based on 1492 Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.